Clinical Trials · NCT02298192
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 420
- Start date
- Nov 2014
- Locations
- 84 sites, 9 countries
- Primary endpoint
- Change From Baseline in HbA1c